{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:20:03Z","timestamp":1763036403034},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.cld.2009.02.003","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T08:33:16Z","timestamp":1242203596000},"page":"267-275","source":"Crossref","is-referenced-by-count":20,"title":["Management of Alcoholic Liver Disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Michael R.","family":"Lucey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8981","key":"10.1016\/j.cld.2009.02.003_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(95)91685-7","article-title":"Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver","volume":"346","author":"Teli","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cld.2009.02.003_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02235538","article-title":"Natural history of alcoholic hepatitis. I. The acute disease","volume":"16","author":"Lischner","year":"1971","journal-title":"Am J Dig Dis"},{"issue":"3","key":"10.1016\/j.cld.2009.02.003_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-9343(68)90111-3","article-title":"Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease","volume":"44","author":"Powell","year":"1968","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cld.2009.02.003_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/lt.500030311","article-title":"Definition and diagnosis of relapse to drinking","volume":"3","author":"Fuller","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2009.02.003_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/jlts.2000.18497","article-title":"Interpreting the significance of drinking by alcohol-dependent liver transplant patients: fostering candor is the key to recovery","volume":"6","author":"Weinrieb","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2009.02.003_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/lt.20934","article-title":"Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease","volume":"13","author":"Pfitzmann","year":"2007","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2009.02.003_bib7","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/j.1572-0241.2008.01837.x","article-title":"Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver function","volume":"103","author":"Lucey","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2009.02.003_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1300\/J069v20n02_09","article-title":"Drinking behavior and motivation for treatment among alcohol-dependent liver transplant candidates","volume":"20","author":"Weinrieb","year":"2001","journal-title":"J Addict Dis"},{"issue":"2","key":"10.1016\/j.cld.2009.02.003_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1176\/appi.psy.42.2.110","article-title":"Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed","volume":"42","author":"Weinrieb","year":"2001","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.cld.2009.02.003_bib10","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1530-0277.1998.tb03912.x","article-title":"Matching alcoholism treatments to client heterogeneity: project MATCH three-year drinking outcomes","volume":"22","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2009.02.003_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jama.281.14.1318","article-title":"Pharmacological treatment of alcohol dependence: a review of the evidence","volume":"281","author":"Garbutt","year":"1999","journal-title":"JAMA"},{"issue":"9603","key":"10.1016\/j.cld.2009.02.003_bib12","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0140-6736(07)61789-9","article-title":"Baclofen for alcoholism","volume":"370","author":"Garbutt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2009.02.003_bib13","first-page":"1075","article-title":"Fulminant hepatitis induced by disulfiram in a patient with alcoholic cirrhosis. Survival after liver transplantation","volume":"13","author":"Vanjak","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cld.2009.02.003_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0168-8278(94)80249-1","article-title":"Disulfiram-induced hepatitis. Report of four cases and review of the literature","volume":"21","author":"Forns","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJMct0801733","article-title":"Naltrexone for the management of alcohol dependence","volume":"359","author":"Anton","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.003_bib16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.003_bib17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2009.02.003_bib18","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2009.02.003_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1530-0277.2007.00593.x","article-title":"Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics","volume":"32","author":"Lucey","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"issue":"9013","key":"10.1016\/j.cld.2009.02.003_bib20","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(96)91682-7","article-title":"Comparison of acamprosate and placebo in long-term treatment of alcohol dependence","volume":"347","author":"Whitworth","year":"1996","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.cld.2009.02.003_bib21","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cld.2009.02.003_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1001\/archinte.168.11.1188","article-title":"Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial","volume":"168","author":"Johnson","year":"2008","journal-title":"Arch Intern Med"},{"issue":"9603","key":"10.1016\/j.cld.2009.02.003_bib23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2009.02.003_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.003_bib26","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2009.02.003_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003045","article-title":"Anabolic-androgenic steroids for alcoholic liver disease","author":"Rambaldi","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2009.02.003_bib28","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.003_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.003_bib30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.003_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2036.2003.01660.x","article-title":"Nutritional therapy in alcoholic liver disease","volume":"18","author":"Stickel","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2009.02.003_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis","volume":"1","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-8278(01)00228-8","article-title":"Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing","volume":"36","author":"Veldt","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.510290308","article-title":"Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis","volume":"29","author":"Frieden","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.003_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.510270404","article-title":"Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis","volume":"27","author":"Corrao","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.003_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198712033172301","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil","volume":"317","author":"Orrego","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.003_bib39","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM198806303182602","article-title":"Colchicine in the treatment of cirrhosis of the liver","volume":"318","author":"Kershenobich","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.003_bib40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0168-8278(94)80005-7","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: influence of drop-out rates and of continued alcohol consumption in a clinical trial","volume":"20","author":"Orrego","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib42","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2005.01.057","article-title":"Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival","volume":"128","author":"Morgan","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.003_bib43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial","volume":"4","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.003_bib44","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","article-title":"II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cld.2009.02.003_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cld.2007.04.014","article-title":"Liver transplantation for alcoholic liver disease","volume":"11","author":"Lucey","year":"2007","journal-title":"Clin Liver Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326109000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326109000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:23:27Z","timestamp":1545265407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326109000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1089326109000051"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2009.02.003","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}